Cubist Systematic Strategies’s Cytek Biosciences CTKB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $329K | Buy |
96,844
+39,431
| +69% | +$134K | ﹤0.01% | 1134 |
|
|
2025
Q1 | $230K | Sell |
57,413
-59,211
| -51% | -$237K | ﹤0.01% | 1158 |
|
|
2024
Q4 | $757K | Buy |
+116,624
| New | +$757K | ﹤0.01% | 880 |
|
|
2023
Q4 | – | Sell |
-14,995
| Closed | -$82.8K | – | 2250 |
|
|
2023
Q3 | $82.8K | Buy |
+14,995
| New | +$82.8K | ﹤0.01% | 1656 |
|
|
2023
Q2 | – | Sell |
-35,172
| Closed | -$323K | – | 2417 |
|
|
2023
Q1 | $323K | Sell |
35,172
-55,268
| -61% | -$508K | ﹤0.01% | 1997 |
|
|
2022
Q4 | $923K | Buy |
90,440
+46,074
| +104% | +$470K | 0.01% | 1811 |
|
|
2022
Q3 | $653K | Sell |
44,366
-39,758
| -47% | -$585K | ﹤0.01% | 2338 |
|
|
2022
Q2 | $903K | Sell |
84,124
-151,509
| -64% | -$1.63M | 0.01% | 2188 |
|
|
2022
Q1 | $2.54M | Buy |
+235,633
| New | +$2.54M | 0.02% | 1284 |
|
|
2021
Q4 | – | Sell |
-8,600
| Closed | -$184K | – | 3488 |
|
|
2021
Q3 | $184K | Buy |
+8,600
| New | +$184K | ﹤0.01% | 2606 |
|